Credit: Wyss Institute at Harvard University
New findings show programmable biomaterials can be delivered using needle injection to induce an immune response and fight deadly diseases
One of the reasons cancer is so deadly is that it can evade attack from the body’s immune system, which allows tumors to flourish and spread. Scientists can try to induce the immune system, known as immunotherapy, to go into attack mode to fight cancer and to build long lasting immune resistance to cancer cells. Now, researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard’s School of Engineering and Applied Sciences (SEAS) show a non–surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer and also infectious disease such as HIV. Their findings are reported in Nature Biotechnology.
“We can create 3D structures using minimally–invasive delivery to enrich and activate a host’s immune cells to target and attack harmful cells in vivo,” said the study’s senior author David Mooney, Ph.D., who is a Wyss Institute Core Faculty member and the Robert P. Pinkas Professor of Bioengineering at Harvard SEAS.
Tiny biodegradable rod–like structures made from silica, known as mesoporous silica rods (MSRs), can be loaded with biological and chemical drug components and then delivered by needle just underneath the skin. The rods spontaneously assemble at the vaccination site to form a three–dimensional scaffold, like pouring a box of matchsticks into a pile on a table. The porous spaces in the stack of MSRs are large enough to recruit and fill up with dendritic cells, which are “surveillance” cells that monitor the body and trigger an immune response when a harmful presence is detected.
“Nano–sized mesoporous silica particles have already been established as useful for manipulating individual cells from the inside, but this is the first time that larger particles, in the micron–sized range, are used to create a 3D in vivo scaffold that can recruit and attract tens of millions of immune cells,” said co-lead author Jaeyun Kim, Ph.D., an Assistant Professor of Chemical Engineering at Sungkyunkwan University and a former Wyss Institute Postdoctoral Fellow.
Synthesized in the lab, the MSRs are built with small holes, known as nanopores, inside. The nanopores can be filled with specific cytokines, oligonucleotides, large protein antigens, or any variety of drugs of interest to allow a vast number of possible combinations to treat a range of infections.
“Although right now we are focusing on developing a cancer vaccine, in the future we could be able to manipulate which type of dendritic cells or other types of immune cells are recruited to the 3D scaffold by using different kinds of cytokines released from the MSRs,” said co-lead author Aileen Li, a graduate student pursuing her Ph.D. in bioengineering at Harvard SEAS. “By tuning the surface properties and pore size of the MSRs, and therefore controlling the introduction and release of various proteins and drugs, we can manipulate the immune system to treat multiple diseases.”
The Latest on: Injectable 3D vaccines
[google_news title=”” keyword=”Injectable 3D vaccines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Injectable 3D vaccines
- CDC Reports First Investigation of HIV Transmission via Cosmetic Injectionson April 26, 2024 at 9:30 am
Three women tested positive for HIV after receiving vampire facials from a New Mexico salon, marking the first CDC investigation to associate transmission of the disease with cosmetic injections.
- Portable MRI, water from air—Indian deep tech startups thriving with incubators, govt fundingon April 18, 2024 at 11:26 pm
Uravu Labs makes water from air, Saaf Biogas makes zero-emission gas & Voxelgrids has built the first made-in-India MRI. Innovation thrives in intersection of academia, entrepreneurship, and govt ...
- Needle-Free Vaccines: Leading Innovation in Drug Deliveryon April 18, 2024 at 2:28 pm
Experts discuss alternative administration roots and why they matter. Megan Livingston, Vice President of Business Development, Jurata Thin Film Inc. Gunilla B. Jacobson, Director of Translational ...
- COVID-19 vaccines: Get the factson April 17, 2024 at 5:45 am
In some people, COVID-19 vaccines can lead to heart complications called myocarditis and pericarditis. Myocarditis is the swelling, also called inflammation, of the heart muscle. Pericarditis is the ...
- Toward A Universal Covid Vaccineon April 10, 2024 at 9:54 am
Over time, the virus develops a series of mutations in the Spike protein and other genes that aid in immune evasion, resulting in a new variant and reduced efficacy for the latest vaccine. The need ...
- Sanofi’s new polio vaccine gets nod in India amid speculations of potential shortageon April 7, 2024 at 10:42 pm
According to a report by PTI, this new vaccine will replace the Inactivated Polio Vaccine (IPV) ShanIP in India. IMOVAX-Polio is an alternative IPV vaccine that has been used in more than 100 ...
via Bing News
